the world's headlines, one feed
Revolution Medicines executives say they're ready to launch what is arguably the biopharma industry's most highly anticipated experimental therapy. The drug, daraxonrasib, is awaiting an approval decision from the US and Europe for metastatic pancreatic ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.
A prescription form of THC helped many people with PTSD escape recurring trauma-related nightmares, with more than one-third reporting that the nightmares disappeared completely after ten weeks.
Health officials say the current epidemic is spreading five times faster than previous outbreaks did at this stage.
The FDA has approved Moderna’s influenza vaccine, the first licensed flu shot made using messenger RNA technology.
The transaction includes a sale of 100% stake by existing shareholders, as well as a commitment to deploy fresh capital to fund its growth and repay debt.
Findings published in the journal Annals of the Rheumatic Diseases underscore the importance for healthcare providers and policymakers to recognise the impact air pollution can have on how one manages…